Image

Evaluation of a Non-invasive Urinary Collection Technique for the Adaptation of Diuretic Treatment in Incontinent Heart Failure Patient Over 75 Years of Age in the Acute Phase

Recruiting
75 - 100 years of age
Both
Phase N/A

Powered by AI

Overview

Heart failure is a general disease affecting many organs and regulatory systems with a prevalence of 10% after 75 years of age, leading to significant hospitalization in the elderly. This generates a significant cost for our health system. The management of patients over 75 years of age in acute heart failure requires special monitoring of diuresis and weight. However, it is sometimes difficult to collect urine from incontinent elderly patients (not catheterized, habitually wearing protection) under intravenous diuretics. The evaluation of a non-invasive technique of urine collection for the adaptation of diuretic treatment in the incontinent patient with heart failure over 75 years of age in the acute phase seems to us to be interesting to conduct.

Eligibility

Inclusion Criteria:

  • Patient over 75 years of age
  • Geriatric short-stay inpatient, geriatric/cardio medicine unit geriatrics
  • Incontinent patient with urinary protection
  • Patient with acute heart failure according to the diagnosis made by the doctors of unity
  • Patient treated with intravenous diuretic
  • Patient benefiting from a social security scheme or benefiting from it by a third party
  • Patient who gave their non-opposition to the study after clear information

Exclusion Criteria:

  • Patient hospitalized in another unit of the geriatric division
  • Patient allergic to the protections provided
  • Patient carrying a bladder probe upon entry into the unit
  • Patient with a precarious non-perfusable venous capital

Study details

Diuresis in Incontinent Patients

NCT05186428

Poitiers University Hospital

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.